Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
WIRE - Novel Treatments in Renal Cell Cancer
- Status
- RECRUITING
- Phase
- PHASE2
PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase I Study of MEDI9447 (Oleclumab) in Japanese Patients
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
PUMA Implementation 2
- Status
- UNKNOWN
- Phase
- N/A
AZD4635 Relative Bioavailability Study
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3